Abstract
Autophagy is a self-degradative pathway involving intracellular substance degradation and recycling. Recently, this process has attracted a great deal of attention for its fundamental effect on physiological processes in cells, tissues, and the maintenance of organismal homeostasis. Dysregulation of autophagy occurs in some diseases, including immune disease, cancer, and neurodegenerative conditions. Diabetic retinopathy (DR), as a serious microvascular complication of diabetes, is the main cause of visual loss in working-age adults worldwide. The pathogenic mechanisms of DR are thought to be associated with accumulation of oxidative stress, retinal cell apoptosis, inflammatory response, endoplasmic reticulum (ER) stress, and nutrient starvation. These factors are closely related to the regulation of autophagy under pathological conditions. Increasing evidence has demonstrated the potential role of autophagy in the progression of DR through different pathways. However, to date this role is not understood, and whether the altered level of autophagy flux protects DR, or instead aggravates the progression, needs to be explored. In this review, we explore the alterations and functions of autophagy in different retinal cells and tissues under DR conditions, and explain the mechanisms involved in DR progression. We aim to provide a basis on which DR associated stress-modulated autophagy may be understood, and to suggest novel targets for future therapeutic intervention in DR.
Highlights
The occurrence of diabetes mellitus (DM) globally is increasing markedly, and is estimated to reach 7.7% by 2030 [1]
Diabetic retinopathy (DR) is a serious microvascular complication of DM, with underlying pathogenic mechanisms derived from multiple risk factors
Hyperglycemia at an early stage and hypoxia at later stages of DR are two of the main aggressors related to retinal pathologic alterations, including induction of ischemia, oxidative stress, endoplasmic reticulum (ER) stress, inflammation, and altered growth factors
Summary
The occurrence of diabetes mellitus (DM) globally is increasing markedly, and is estimated to reach 7.7% by 2030 [1]. It is well-recognized that many complications result from uncontrolled diabetes, affecting the cardiovascular system and contributing to kidney failure, peripheral vascular diseases, and other pathologies [2]. Diabetic retinopathy (DR) is a microvascular disease resulting from DM and is the leading cause of visual dysfunction and blindness in adults worldwide [3]. DR is initially induced by long periods of extremely high glucose (HG), and is characterized by breakdown of the blood–retinal barrier (BRB), with increased permeability and neovascularization [4]. The detailed molecular and pathologic mechanisms of DR are not fully understood.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.